Anidulafungin for candidemia/invasive candidiasis in non-neutropenic ICU patients

被引：0
|
作者：
M Ruhnke
J Paiva
W Meersseman
J Pachl
I Grigoras
G Sganga
F Menichetti
P Montravers
G Auzinger
G Dimopoulos
M Borges Sá
P Miller
T Marček
M Kantecki
机构：
[1] Charité University Hospital,
[2] Hospital São João,undefined
[3] University Hospital Leuven,undefined
[4] University Hospital Královské Vinohrady,undefined
[5] University Hospital Sf Spiridon,undefined
[6] University Hospital A Gemelli,undefined
[7] University Hospital Pisa,undefined
[8] Hospital Bichat Claude Bernard,undefined
[9] King's College Hospital,undefined
[10] University Hospital Attikon,undefined
[11] Hospital Son Llatzer,undefined
[12] Pfizer,undefined
[13] Pfizer,undefined
来源：
Critical Care | / 15卷 / Suppl 1期
关键词：
Candidiasis; Azole; Global Response; Anidulafungin; Sofa Score;
D O I：
10.1186/cc9660
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Practical considerations on current guidelines for the management of non-neutropenic adult patients with candidaemia
    Gloeckner, A.
    Cornely, O. A.
    MYCOSES, 2013, 56 (01) : 11 - 20
  • [32] Anidulafungin Versus Micafungin in the Treatment of Candidemia in Adult Patients
    Jin Woong Suh
    Sun Bean Kim
    Young Kyung Yoon
    Jang Wook Sohn
    Min Ja Kim
    Jong Hun Kim
    Mycopathologia, 2020, 185 : 653 - 664
  • [33] Anidulafungin Versus Micafungin in the Treatment of Candidemia in Adult Patients
    Suh, Jin Woong
    Kim, Sun Bean
    Yoon, Young Kyung
    Sohn, Jang Wook
    Kim, Min Ja
    Kim, Jong Hun
    MYCOPATHOLOGIA, 2020, 185 (04) : 653 - 664
  • [34] Clinical Experience of Anidulafungin for the Treatment of Patients with Documented Candidemia
    Falcone, M.
    Russo, A.
    De Rosa, F. G.
    Pasero, D.
    Toma, L.
    Raponi, G.
    Ghezzi, M. C.
    Venditti, M.
    JOURNAL OF CHEMOTHERAPY, 2010, 22 (06) : 397 - 401
  • [35] ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
    Cornely, O. A.
    Bassetti, M.
    Calandra, T.
    Garbino, J.
    Kullberg, B. J.
    Lortholary, O.
    Meersseman, W.
    Akova, M.
    Arendrup, M. C.
    Arikan-Akdagli, S.
    Bille, J.
    Castagnola, E.
    Cuenca-Estrella, M.
    Donnelly, J. P.
    Groll, A. H.
    Herbrecht, R.
    Hope, W. W.
    Jensen, H. E.
    Lass-Floerl, C.
    Petrikkos, G.
    Richardson, M. D.
    Roilides, E.
    Verweij, P. E.
    Viscoli, C.
    Ullmann, A. J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 : 19 - 37
  • [36] Risk factors for Candida colonization/infection in non-neutropenic medical critically ill patients
    J Nolla
    C León
    R Jordá
    MA León
    MJ Pontes
    M Casado
    Critical Care, 5 (Suppl 1):
  • [37] Therapeutic variability in the treatment of Candida colonization/infection in non-neutropenic critically ill patients
    C León
    J Nolla
    R Jordá
    MA León
    MJ Pontes
    A Loza
    Critical Care, 5 (Suppl 1):
  • [38] Treatment of invasive candidiasis in neutropenic patients: systematic review of randomized controlled treatment trials
    Kanji, Jamil N.
    Laverdiere, Michel
    Rotstein, Coleman
    Walsh, Thomas J.
    Shah, Prakesh S.
    Haider, Shariq
    LEUKEMIA & LYMPHOMA, 2013, 54 (07) : 1479 - 1487
  • [39] Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial
    Vazquez, Jose
    Reboli, Annette C.
    Pappas, Peter G.
    Patterson, Thomas F.
    Reinhardt, John
    Chin-Hong, Peter
    Tobin, Ellis
    Kett, Daniel H.
    Biswas, Pinaki
    Swanson, Robert
    BMC INFECTIOUS DISEASES, 2014, 14
  • [40] Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial
    Jose Vazquez
    Annette C Reboli
    Peter G Pappas
    Thomas F Patterson
    John Reinhardt
    Peter Chin-Hong
    Ellis Tobin
    Daniel H Kett
    Pinaki Biswas
    Robert Swanson
    BMC Infectious Diseases, 14
12345